SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): January 17, 2012

Corgenix Medical Corporation

(Exact Name of registrant as specified in its charter)

11575 Main Street

Suite 400

Broomfield, Colorado 80020

(Address, including zip code, of principal executive offices)

(303) 457-4345

(Registrant’s telephone number including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o            Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At the annual meeting of the shareholders of Corgenix Medical Corporation (the “Company”) held on January 17, 2012 (the “Annual Meeting of Shareholders”), the Company’s shareholders approved the Corgenix Medical Corporation 2011 Incentive Compensation Plan (the “2011 Incentive Plan”) and the Corgenix Medical Corporation Third Amended and Restated Employee Stock Purchase Plan (the “Employee Stock Purchase Plan,” together with the 2011 Incentive Plan, the “Plans”).  The Plans had been previously approved, subject to shareholder approval, by the Board of Directors of the Company.

A description of the material terms of the 2011 Incentive Plan is set forth under the heading “Proposal 3 — Approval of the 2011 Incentive Compensation Plan” in the Company’s proxy statement filed with the Securities and Exchange Commission on December 5, 2011, which description is hereby incorporated by reference into this Item 5.02(e). In addition, a copy of the 2011 Incentive Plan was filed with the Company’s Schedule 14A on December 5, 2011, as Appendix A, and is incorporated herein by reference, and the summary is qualified in its entirety by reference to the terms and provisions of the 2011 Incentive Plan.

A description of the material terms of the Employee Stock Purchase Plan is set forth under the heading “Proposal 4 — Approval of the Third Amended and Restated Employee Stock Purchase Plan” in the Company’s proxy statement filed with the Securities and Exchange Commission on December 5, 2011, which description is hereby incorporated by reference into this Item 5.02(e). In addition, a copy of the Employee Stock Purchase Plan was filed with the Company’s Schedule 14A on December 5, 2011, as Appendix B, and is incorporated herein by reference, and the summary is qualified in its entirety by reference to the terms and provisions of the Employee Stock Purchase Plan.

Item 5.07.  Submission of Matters to a Vote of Security Holders.

On January 17, 2012, the Company held its Annual Meeting of Shareholders, where the shareholders were asked to vote on the matters set forth below:

1.               Proposal to elect seven directors to serve under the next annual meeting of shareholders and until their successors have been duly elected and qualified.  Proxies were solicited by management in favor of the director nominees, with no solicitation in opposition to management’s nominees.  The director nominees were elected to serve for a period of one year until the Company’s next Annual Meeting of Shareholders.  The number of votes cast for, against, or withheld, as well as the number of broker non-votes, for each nominee was as follows:

2.               Proposal to ratify the appointment of Hein & Associates LLP as the Company’s independent public accountants for the fiscal year ending June 30, 2012.  The number of votes cast for, against, or abstained were as follows:

2

3.               Proposal to approve the Corgenix Medical Corporation 2011 Incentive Compensation Plan.  The number of votes cast for, against, or abstained were as follows:

4.               Proposal to approve the Corgenix Medical Corporation Third Amended and Restated Employee Stock Purchase Plan.  The number of votes cast for, against, or abstained were as follows:

Item 7.01.  Regulation FD Disclosure.

At the Annual Meeting of Shareholders on January 17, 2012, the Company’s President and Chief Executive Officer and Chief Financial Officer presented materials to shareholders which are filed as Exhibit 99.1 hereto and incorporated by reference.

Item 9.01.  Financial Statements and Exhibits.

(d) Exhibits

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

4

EXHIBIT INDEX

5